4:32 PM ET
10-Q
Financial Results
Sunshine Biopharma Q3 2026 Results: Net Loss of $1.22M, Loss Widens
Sunshine Biopharma Inc. reported a net loss of $4.03 million for the nine months ended September 30, 2026, compared to a loss of $3.83 million in the prior year period. While revenues decreased slightly to $26.79 million, the company significantly strengthened its cash position to $14.62 million through public offerings and warrant exercises.
- Key figure
- Net loss $1.22M